(b)(4).Internal file number - (b)(4): during processing of this complaint, attempts were made to obtain complete event, patient and device information.Date of event - estimated.There was no reported device malfunction and the product was not returned as it remains implanted.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect of stenosis is listed in the xience xpedition, everolimus eluting coronary stent system (eecss), instructions for use as a known patient effect of coronary stenting procedures.A conclusive cause for the reported patient effects and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
|
It was reported that on (b)(6) 2014, the patient was hospitalized with intermittent chest pain.A 3.25x38mm xience xpedition stent was implanted in the 80% stenosed proximal left anterior descending (lad) coronary artery and was discharged on (b)(6) 2014.In (b)(6) 2016, the patient was re-hospitalized due to syncope.Coronary angiography was performed and may have noted restenosis in one end of the stent.The patient was given medication.The condition improved and the patient was discharged.Per physician, the relationship between the event and the device is related.No additional information was provided.
|